Events
Search Results
WSGR Events
6.04.26
2026 Medical Device & Digital Health Conference
Wilson Sonsini’s 33rd Annual Medical Device & Digital Health Conference convenes industry leaders, investors, and innovators to explore the forces shaping medical device technology and digital health today. The program delivers valuable insights across innovation, regulation, capital markets, and commercialization, addressing topics of critical importance to companies navigating strategic growth and transformation.
Affiliated Programs
1.12.26
MedTech Innovator and BioTools Innovator's 2026 Innovator Forum
Wilson Sonsini is pleased to be the exclusive sponsor of The 2026 Innovator Forum during JPM week. Hosted jointly by MedTech Innovator and BioTools Innovator, the Innovator Forum convenes vetted alumni startups, investors, and corporate strategics for a focused day of high-impact partnering during JPM week.
Speaking Engagements
12.10.25
Colorado BioScience Association Thought Leadership Series: Finding Success in a Challenging Funding Environment
Wilson Sonsini, in partnership with EY and Colorado BioScience Association, invites you to an in-depth program bringing together leaders, investors, and innovators from across Colorado’s life sciences ecosystem discussing our current funding environment.
Affiliated Programs
11.18.25
BioTools Innovator 2025 Capstone Event
Wilson Sonsini is proud to be an event sponsor for the Biotools Innovator Capstone Event on November 18th. The BioTools Innovator Capstone is the premier showcase for innovation in life science tools and diagnostics, bringing together leading pharma and biotech startups to present their groundbreaking technologies to a panel of judges, including Wilson Sonsini partners, Eric Hsu, Ingo Hardt, Marty Waters, and Bu Yin.
WSGR Events
10.08.25
Phoenix 2025: The Medical Device & Diagnostics Conference for CEOs
The 30th Annual Phoenix Conference will bring together top-level executives from large healthcare companies and CEOs of small, venture-backed firms for an opportunity to discuss critical issues of interest to the medical device industry today, as well as to network and gain valuable insights from both industry leaders and peers. This exclusive, two-day in-person event will provide an unrivaled experience that will help inform and shape company strategy for the years ahead.
Speaking Engagements
9.10.25
From Lab to Launch: Navigating IVD/LDT Reimbursement, Regulatory, and Investment Hurdles
On September 10, 2025, Wilson Sonsini's Eva Yin, Partner, and Matthew Meyer, Chief Business Advisor, will participate in the “From Lab to Launch” webinar, hosted by GenoSan. Eva will present on FDA regulatory pathways and compliance considerations for diagnostics companies entering the U.S. market. Matthew will offer insights on how life sciences startups can effectively pitch to venture capital firms, drawing on his experience advising diagnostics and biopharma companies. The webinar is designed for innovators, entrepreneurs and industry executives preparing to bring new diagnostic technologies to market. For more information about the event, you can visit the event website.
Affiliated Programs
9.04.25
Kickoff Event: Keys to Succeeding in the Japanese Healthcare Market – Presented by the Japan Society of Northern California and RAPS
Wilson Sonsini is pleased to sponsor the US-Japan Healthcare Innovation Conference and their associated kick-off events.
WSGR Events
6.05.25
2025 Medical Device & Digital Health Conference
Wilson Sonsini’s 32nd Annual Medical Device & Digital Health Conference will address topics of critical importance to medical device and digital health companies.
Affiliated Programs
4.02.25
2025 BIOCOM Converge Summit
Wilson Sonsini is pleased to support Biocom’s Converge Summit. This year, our patents and innovations partner Ali Alemozafar will moderate the panel "VC Perspectives." Panelists include Benjamin Kim, Ph.D., Partner at Playground Global; Emily Park, M.D., Principal at DCVC Bio; Ben Portnoy, Ph.D., Investment Partner at Andreessen Horowitz; Elena Viboch, Managing Director at General Catalyst; and D.A. Wallach, Co-Founder and General Partner at Time BioVentures.